Effect of olezarsen on lipoprotein-associated ApoC-III levels in patients with familial chylomicronemia syndrome. Yang X, Alexander VJ, Xia S, Tsimikas S, et al. Atherosclerosis 2025;408:120462.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang X, Alexander VJ, Xia S, Tsimikas S, et al. Effect of olezarsen on lipoprotein-associated ApoC-III levels in patients with familial chylomicronemia syndrome. Atherosclerosis 2025;408:120462.
PMID: 40706406